Guidelines for the Management of Pediatric Heart Failure: Executive Summary

Published 16 June 2014

Richard Kirk, MA, FRCP, FRCPCH; Anne I. Dipchand, MD, FRCPC; David N. Rosenthal, MD; Linda Addonizio, MD; Michael Burch, MD; Maryanne Chrisant, MD; Anne Dubin, MD; Melanie Everitt, MD; Robert Gajarski, MD; Luc Mertens, MD; Shelley Miyamoto, MD; David Morales, MD; Elfriede Pahl, MD; Robert Shaddy, MD; Jeffrey Towbin, MD; Robert Weintraub, MD

J Heart Lung Transplant. 2014 Sep; 33(9):888-909

• Advanced Heart Failure & Transplantation
• Anesthesiology & Critical Care
• Cardiology
• Executive Summary
• Nursing & Allied Health
• Pediatrics
• Pharmacy
• Professional Guideline
• Publications & Journals
• Research & Immunology
• Standards & Guidelines

These guidelines have been produced to bring together current recommendations on the evaluation and management of pediatric heart failure (HF) and update the previous guideline.

The writing group was chosen from the membership of the International Society for Heart and Lung Transplantation (ISHLT), the Association of European Pediatric and Congenital Cardiology (AEPC), and the Pediatric and Congenital Electrophysiology Society (PACES) across health care disciplines to achieve representation of HF practice throughout the world. Overall, 90 contributors from 13 counties across 4 continents were assigned various aspects of HF according to their expertise. The topics covered include definition and documentation, genetic testing, diagnostics, pharmacologic treatment of chronic reduced EF (systolic HF), pharmacologic treatment of "preserved EF (diastolic HF), electrophysiology intervention, MCS, comorbidity, acute HF, transplantation listing, and health care delivery.

Read at JHLT